Day: June 24, 2022

2 beaten down ASX shares named as buys by experts

Woman smashes dollar sign for dividend share investment

Woman smashes dollar sign for dividend share investment

A number of shares have been beaten down this year following the mini market crash.

While this is disappointing, it could have created a buying opportunity for investors once the volatility ends. Here’s why these ASX shares could be top options:

Altium Limited (ASX: ALU)

The first beaten down ASX share for investors to look at is Altium. It is the electronic design software provider behind the Altium 365 and Altium Designer platforms, the Nexus collaboration platform, and the Octopart search engine.

The Altium share price is down 37% since the start of the year. This could be a buying opportunity according to analysts at Bell Potter. They currently have a buy rating and $34.00 price target on Altium’s shares. This implies potential upside of 21% for investors over the next 12 months.

Bell Potter’s analysts believe Altium is “on track to achieve its FY22 guidance and expect much better subscriber growth in 2HFY22 relative to 1HFY22.”

Domino’s Pizza Enterprises Ltd (ASX: DMP)

Another beaten down ASX share to look at is Domino’s. It is one of the world’s largest pizza chain operators with stores across the ANZ, Asia-Pacific, and European regions.

Its shares have fared even worse than Altium’s in 2022 and are down 46% since the turn of the year. Morgans believes this weakness is a buying opportunity and recently put an add rating and $93.00 price target on its shares. This implies potential upside of 40% for investors between now and this time next year.

Morgans remains positive on the company due to its store rollout plan, which it notes is “the engine of DMP’s growth.” And while near term trading conditions may be tough, the broker believes “the medium-term opportunity is absolutely undiminished.”

The post 2 beaten down ASX shares named as buys by experts appeared first on The Motley Fool Australia.

Should you invest $1,000 in Altium Limited right now?

Before you consider Altium Limited, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Altium Limited wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

See The 5 Stocks
*Returns as of June 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Altium. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/VgJBc8T

Analysts name 2 excellent ASX shares to buy and hold

smiling man holding phone technology

smiling man holding phone technology

There are a lot of shares to choose from on the Australian share market.

In order to narrow things down for investors, listed below are two ASX shares that are rated highly by analysts. Here’s why they could be top buy and hold options:

Lovisa Holdings Limited (ASX: LOV)

The first ASX share that could be a top buy and hold option is Lovisa.

Morgans is very positive on Lovisa due to its global expansion plans and its new and highly experienced CEO, Victor Herrero. The broker sees a huge opportunity for Lovisa in the massive US market. It explained:

Lovisa’s global footprint now spans 22 countries. In our opinion, investors can expect this number to increase steadily while, at the same time, Lovisa builds out its presence in its existing markets. We do not think there is any lack of opportunity. In the US, for example, Lovisa now has 81 stores, representing 0.25 stores for every million people), compared to Australia with 158 stores, 6.15 stores for every million people.

Morgans has an add rating and $24.00 price target on its shares.

TechnologyOne Ltd (ASX: TNE)

Another ASX share that could be a top buy and hold option is TechnologyOne. It is an enterprise software provider servicing the government, financial services, health and community services, education, and utilities and managed services markets.

TechnologyOne appears well-placed for growth thanks to its shift to a software-as-a-service (SaaS) model and its UK expansion. It also has defensive qualities, which Goldman Sachs finds particularly attractive in the current environment. It commented:

Defensive end markets (public sector and education) with IT spending that are relatively resilient to recessions. Contractual CPI pricing pass-through, high recurring revenue, minimal churn (<1%), high margins and net cash are attractive attributes in a slowing economy. In addition, TNE’s recent result highlight continued momentum towards the +A$500mn FY26 ARR target, providing valuable earnings growth visibility over coming years, in our view.

Goldman has a buy rating and $13.30 price target on the company’s shares.

The post Analysts name 2 excellent ASX shares to buy and hold appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of June 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Lovisa Holdings Ltd and TechnologyOne Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/SsfFcAl

Why Goldman Sachs sees 13% upside for the ResMed share price

An ASX shares broker analysing a chart tracking the A2 Milk share price

An ASX shares broker analysing a chart tracking the A2 Milk share price

The ResMed Inc (ASX: RMD) share price was on form on Friday.

The sleep treatment focused medical device company’s shares rose almost 3% to $30.45.

Can the ResMed share price keep rising?

The good news for investors is that one leading broker still sees plenty of room for the ResMed share price to keep rising.

According to a recent note out of Goldman Sachs, its analysts have a buy rating and $34.40 price target on its shares.

This implies potential upside of 13% for investors over the next 12 months.

What did the broker say?

Goldman notes that ResMed has announced plans to acquire Medifox Dan for US$1 billion.

It is an out-of-hospital software provider based in Germany which generated revenue of US$83 million and EBITDA of US$35 million in calendar year 2021.

Goldman appeared pleased with the deal. It commented:

The acquisition goes some way to answering a long-held question the market has had around when/how the company would attempt to replicate its SaaS strategy outside of the US market.

What else is the broker saying?

Its analysts also highlight that the ResMed share price has been underperforming in FY 2022 due to concerns over supply chain headwinds. This has stopped the company from taking full advantage of a major product recall from rival Philips.

However, Goldman feels the market is overreacting and expects elevated demand to stick around long enough for ResMed to benefit. It also sees a backlog of patients waiting to be diagnosed as a potential upside risk to estimates.

Its analysts explained:

We believe the elevation in demand could persist beyond the time it takes for component shortages to improve (via both external and internal factors) and, as such, the YTD underperformance of the shares may be over-capitalising relatively short-term headwinds.

We believe the backlog of new patients may add upside to our estimates if there is a material realisation of incremental devices/masks sales to new patients in FY23/24 (supply chain pressures permitting). The return of PHIA to the market may actually help in this regard, as the company supplies critical diagnosis equipment.

The post Why Goldman Sachs sees 13% upside for the ResMed share price appeared first on The Motley Fool Australia.

Should you invest $1,000 in Resmed Inc. right now?

Before you consider Resmed Inc., you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Resmed Inc. wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

See The 5 Stocks
*Returns as of June 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs and ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/zljuMb2

Down 18% in a week, what’s stolen the shine from the Regis Resources share price?

a young man sits on the floor with his back against a sofa hunched over his phone in one hand and his other hand on top of his head as though he is seeing bad news as his face looks sad and anguised.a young man sits on the floor with his back against a sofa hunched over his phone in one hand and his other hand on top of his head as though he is seeing bad news as his face looks sad and anguised.

The Regis Resources Limited (ASX: RRL) share price has fallen 18% over the past week.

This comes despite the company keeping a relatively quiet profile on the news front.

At Friday’s market close, the gold miner’s shares recovered some lost ground to finish 1.32% higher at $1.54. That’s 18.09% lower than the $1.88 it closed at the previous Friday.

It’s worth noting that Regis Resources shares touched a 52-week low of $1.465 on Friday before quickly reversing their losses.

What’s happening with Regis Resources?

After four consecutive sessions in the red, it appears investors are taking advantage of the Regis Resources share price weakness.

The extreme volatility on the ASX mixed with a deteriorating gold price have caused havoc with the company’s shares.

This is because of fears surrounding more aggressive rate hikes by the Reserve Bank of Australia to cool down inflation.

While the negative news has been priced in, investors will be eagerly awaiting the next consumer price index report. This is scheduled to be released on 27 July and will tell us about the latest inflation levels for the June quarter.

If interest rates are accelerated, it’s possible the Regis Resources share price could fall further as investors switch to government bonds.

At the time of writing, the yellow metal is fetching US$1,823 per ounce. This represents a decline of almost 2% in the past 30 days.

In addition, the S&P/ASX 300 Metals and Mining Industry (ASX: XMM) has also headed south over the past week, down by almost 6%.

The sector contains companies in the top 300 ASX companies that are involved with gold, steel, and precious metals.

Regis Resources share price performance

It’s been a rough ride for Regis shareholders with the company’s shares plummeting by 21% in 2022.

However, when looking at the past 12 months, those losses are further amplified with the Regis Resources share price down 37%.

Based on today’s closing price, the company presides a market capitalisation of approximately $1.15 billion.

The post Down 18% in a week, what’s stolen the shine from the Regis Resources share price? appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of June 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/0pDPHbK